Received: 27 August 2020
Accepted: 14 September 2020
First Online: 22 September 2020
Ethics approval and consent to participate
: The study was approved by the South-Central Hampshire A Research Ethics Committee: REC reference 19/SC/0138, on the 16th March 2020. No patient identifiable data is included in this manuscript.
: Not applicable.
: KS reports grants from AstraZeneca, outside the submitted work. TC reports personal fees from BioMerieux and BioFire LLC, non-financial support from BioMerieux and BioFire LLC, personal fees from Synairgen research ltd, personal fees and other from Roche, personal fees from Cidara therapeutics, personal fees from Janssen and grants from NIHR outside the submitted work. TW reports personal fees from MMH, grants and personal fees from GSK, grants and personal fees from AZ, personal fees from BI, grants and personal fees from Synairgen outside the submitted work. HB, AF, DC, BS, NB, SP, FB, HP, NS, SW and CS have nothing to disclose.